Advertisement
Australia markets closed
  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     
  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     
  • AUD/USD

    0.6604
    -0.0017 (-0.26%)
     
  • OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD

    2,366.90
    +26.60 (+1.14%)
     
  • Bitcoin AUD

    91,811.27
    -3,205.09 (-3.37%)
     
  • CMC Crypto 200

    1,259.41
    -98.60 (-7.26%)
     
  • AUD/EUR

    0.6128
    -0.0010 (-0.16%)
     
  • AUD/NZD

    1.0963
    -0.0006 (-0.05%)
     
  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     
  • NASDAQ

    18,161.18
    +47.72 (+0.26%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • Dow Jones

    39,512.84
    +125.08 (+0.32%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

Company News For Sep 30, 2019

  • Wells Fargo & Co.’s WFC shares surged 3.8% after the company appointed Charles Scharf as chief executive officer, which was vacant for past six months.

  • Pfizer Inc. PFE gained 1.2% following favorable results in a second late-stage trial of its drug for moderate to severe atopic dermatitis.

  • LATAM Airlines Group S.A. LTM shares jumped 31.1% after Delta Air Lines Inc. DAL agreed to acquire 20% stake of the company for $1.9 billion.

  • Shares of Las Vegas Sands Corp. LVS climbed 2.2% following news that the company will enter the benchmark S&P 500 Index on Oct 3 replacing Nektar Therapeutics NKTR.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Delta Air Lines, Inc. (DAL) : Free Stock Analysis Report
 
Las Vegas Sands Corp. (LVS) : Free Stock Analysis Report
 
Wells Fargo & Company (WFC) : Free Stock Analysis Report
 
Pfizer Inc. (PFE) : Free Stock Analysis Report
 
LATAM Airlines Group S.A. (LTM) : Free Stock Analysis Report
 
Nektar Therapeutics (NKTR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research